16 . November , 2018 - Friday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Nesiritide

Big Image Pronouncation: (nih-SIR-ih-tide)
Class: Human B-type natriuretic peptide

Trade Names:
- Powder for injection, lyophilized 1.58 mg

Mechanism of Action


Binds to the particulate guanylate cyclase receptor of vascular smooth muscle and endothelial cells, leading to dose-dependent reductions in pulmonary capillary wedge pressure and systemic arterial pressure in patients with heart failure.



The mean Vd of the central compartment is estimated to be 0.073 L/kg and the mean Cl is approximately 9.2 mL/min/kg. Following IV administration to patients with CHF, disposition from the plasma is biphasic.


The mean terminal elimination t ½ is approximately 18 min and is associated with approximately 2/3 of the AUC. The mean initial elimination phase is about 2 min.


With administration of the recommended dosing regimen of 2 mcg/kg IV bolus followed by 0.01 mcg/kg/min, 60% of the 3-hr effect on pulmonary capillary wedge pressure reduction is achieved within 15 min after the bolus. Approximately 70% of the 3-hr effect on standing BP reduction is reached within 15 min.


95% of the 3-hr effect is achieved within 1 hr.


The pharmacodynamic t ½ of the onset and offset of the hemodynamic effect is longer than predicted by the pharmacokinetic t ½ .

Indications and Usage

Treatment of patients with acutely decompensated CHF who have dyspnea at rest or with minimal activity.


Primary treatment for patients with cardiogenic shock; systolic BP less than 90 mm Hg; hypersensitivity to any component of the product.

Dosage and Administration


IV Recommended dose is 2 mcg/kg IV bolus over 60 sec followed by continuous infusion at a dose of 0.01 mcg/kg/min. If hypotension occurs during administration, reduce or discontinue the dose and start other measures to support BP.

General Advice

  • For IV administration only. Not for intradermal, IM, subcutaneous, or intra-arterial administration.
  • Follow manufacturer's instructions for reconstitution of powder and final dilution for infusion solution.
  • Do not shake or agitate vials during reconstitution or dilution. Do not use filter needles during preparation of infusion.
  • Do not administer if solution is cloudy, discolored, or contains particulate matter.
  • Prime IV tubing with infusion solution prior to connecting to patient's vascular access port and prior to administering bolus dose and starting infusion.
  • Infusion rate may be increased by 0.005 mcg/kg/min, no more often than q 3 hr up to a max of 0.03 mcg/kg/min. Increases in infusion rate should be preceded by a bolus dose of 1 mcg/kg.
  • Do not administer through a central heparin-coated catheter.
  • Flush catheter between administration of nesiritide and any incompatible injectable medication.


Store vials at controlled room temperature (68° to 77°F) in original carton. Use reconstituted solution immediately. If immediate use is not possible, the reconstituted solution may be stored for up to 24 hr in refrigerator (36° to 46°F) or at controlled room temperature.

Drug Interactions

ACE inhibitors (eg, captopril)

Coadministration may cause an increase in symptomatic hypotension.


Physically and chemically incompatible with injectable formulations of bumetanide, enalaprilat, ethacrynate sodium, furosemide, hydralazine, heparin, and insulin. These agents should not be administered as infusions with nesiritide through the same IV catheter. Sodium metabisulfite preservative is incompatible with nesiritide. Since nesiritide binds with heparin, do not administer through a central heparin-coated catheter.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Hypotension (symptomatic and asymptomatic) (11%); ventricular tachycardia (3%); nonsustained ventricular tachycardia (3%); ventricular extrasystoles (3%); angina pectoris; bradycardia; tachycardia; atrial fibrillation; AV node conduction abnormalities.


Headache (8%); insomnia; dizziness (3%); anxiety (3%); confusion; paresthesia; somnolence; tremor.


Sweating; pruritus; rash.




Nausea (4%); vomiting.




Increased cough; hemoptysis; apnea.


Abdominal pain; back pain; catheter pain; fever; injection site reaction; increased creatinine; leg cramps.



Category C .




Safety and efficacy not established.

Renal Function

Renal function may be affected in susceptible patients; azotemia may occur in patients with severe heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system.


Avoid administration in patients suspected of having or known to have low cardiac filling pressures. Not recommended for use in patients for whom vasodilating agents are not approved (eg, significant valvular stenosis; restrictive or obstructive cardiomyopathy).


May occur at recommended or adjustable doses.




Patient Information

  • Explain name, action, dosing regimen, and potential side effects of drug.
  • Advise patient, family, or caregiver that medication will be prepared and administered by highly trained health care providers in an intensive care setting.

Recent Drug Updates at DrugIndexOnline:

Adapalene Adapalene
Pronouncation: (ADE-ah-PALE-een) Class: Retinoid Trade Names: Differin - Cream 0.1% - Gel 0.1% - Solution 0.1% Mechanism of Action Pharmacology May normalize the differentiation of follicular epithelial cells, resulting in decreased microcomedone formation. Indications and Usage Topical treatment o more...

Aluminum/Magnesium Concentrate Aluminum/Magnesium Concentrate
Generic Name: Aluminum/Magnesium Concentrate and Suspension (a-LOO-min-uhm/mag-NEE-zee-uhm) Brand Name: Examples include Alamag and MaaloxAluminum/Magnesium Concentrate is used for:Treating acid indigestion, heartburn, and sour stomach. It may also be used for other conditions as determined by more...

Buspirone Buspirone
Generic Name: Buspirone hydrochloride Dosage Form: Tablets usp Buspirone Description Buspirone hydrochloride is an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs. Buspirone hydrochloride is a white, cr more...

Elocon Cream Elocon Cream
Generic Name: Mometasone Cream and Ointment (moe-MET-a-sone) Brand Name: EloconElocon Cream is used for:Treating itching, redness, and swelling of many skin conditions. Elocon Cream is a topical corticosteroid. It works by reducing inflammatory reactions and modifying immune reactions in the bod more...

Invega Invega
Generic Name: paliperidone (pal ee PER i done) Brand Names: Invega What is paliperidone? Paliperidone is an antipsychotic medication. It works by changing the effects of chemicals in the brain. Paliperidone is used to treat schizophrenia. Paliperidone may also be used for purposes other more...

Kogenate FS injection Kogenate FS injection
Generic Name: antihemophilic factor (factor VIII) (injection) (an TEE hee moe FIH lick FAC tor) Brand Names: Advate rAHF-PFM, Alphanate, Helixate, Helixate FS, Hemofil-M, Humate-P, Koate-DVI, Koate-HP, Kogenate, Kogenate FS, Monarc-M, Monoclate-P, Recombinate, Refacto What is antihemophil more...

Lexiva Lexiva
Generic Name: Fosamprenavir Tablets (FOS-am-PREN-a-veer) Brand Name: LexivaLexiva is used for:Treating HIV infection in some patients when used in combination with certain other medicines. Lexiva is an HIV protease inhibitor. It works by slowing the growth of HIV, the virus that causes AIDS. D more...

Mycogen II topical Mycogen II topical
Generic Name: nystatin and triamcinolone (topical) (NY stat in and try am SIN o lone) Brand Names: Mycasone, Myco Biotic II, Myco-Triacet II, Mycogen II, Mycolog-II, Mycomar, Mytrex, Nyst-Olone II, Tri-Statin II What is nystatin and triamcinolone? Nystatin is an antibiotic medication more...